Central Pharmaceuticals Ltd. Share Price

Equities

CENTRALPHL

BD0487CPL007

End-of-day quote Dhaka S.E. 03:30:00 21/05/2024 am IST 5-day change 1st Jan Change
18.7 BDT -2.60% Intraday chart for Central Pharmaceuticals Ltd. -10.53% -7.43%

Financials

Sales 2022 2.6Cr 2L 1.86Cr Sales 2023 2.93Cr 3L 2.1Cr Capitalization 148.55Cr 1.28Cr 106.29Cr
Net income 2022 -6.8Cr -6L -4.87Cr Net income 2023 -4.4Cr -4L -3.15Cr EV / Sales 2022 70.6 x
Net Debt 2022 27Cr 22.95L 19Cr Net Debt 2023 27Cr 22.98L 19Cr EV / Sales 2023 59.8 x
P/E ratio 2022
-23 x
P/E ratio 2023
-33.8 x
Employees 74
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Central Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022 CI
Central Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2020 CI
Central Pharmaceuticals Ltd. Restates Earnings Results for the Period from January-March 2020 and for the Period from July 2019-March 2020 CI
Central Pharmaceuticals Ltd. Recommends 1% Cash Dividend for the Year Ended on June 30, 2019 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2019 CI
CENTRALPHL Announces Demise of Nashima Akhter, Director on May 18, 2018 CI
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018 CI
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2017 CI
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the First Quarter Ended September 2017 CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2017 CI
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017 CI
More news
1 day-2.60%
1 week-10.53%
Current month-17.62%
1 month-27.24%
3 months-29.96%
6 months+10.00%
Current year-7.43%
More quotes
1 week
18.70
Extreme 18.7
20.30
1 month
18.70
Extreme 18.7
25.30
Current year
16.00
Extreme 16
35.60
1 year
10.80
Extreme 10.8
35.60
3 years
9.90
Extreme 9.9
35.60
5 years
6.60
Extreme 6.6
35.60
10 years
6.60
Extreme 6.6
35.60
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 20/98/20
Director of Finance/CFO - -
Chairman 49 16/07/16
Members of the board TitleAgeSince
Chairman 49 16/07/16
Chief Executive Officer 57 20/98/20
Director/Board Member - -
More insiders
Date Price Change Volume
21/24/21 18.7 -2.60% 4,849,106
20/24/20 19.2 -2.54% 1,464,272
19/24/19 19.7 -2.96% 516,496
16/24/16 20.3 -2.87% 2,073,701
15/24/15 20.9 -2.79% 2,168,080

End-of-day quote Dhaka S.E., May 21, 2024

More quotes
  1. Stock Market
  2. Equities
  3. CENTRALPHL Stock